Onconetix ONCO Cash Flow Statement (2021-2026)

NASDAQ ONCO
$0.78 -0.05 (-5.44%)
At close: Sep 10, 2026 · 4:00 PM EDT
Reported Financials

Onconetix Quarterly Cash Flow Statement

Periods 22 quarters
Latest Jun 2026

Onconetix reported cash from operations of -$1.92M and free cash flow of -$1.92M for the quarter ended Jun 2026, down 36.0% year over year. This cash flow statement covers 22 quarters of results from Mar 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-1.10M-1.20M-2.07M-4.29M-3.87M-3.25M-2.85M-6.87M-5.35M-22.36M-11.12M-14.31M-3.83M-18.00M-8.55M-2.37M-8.78M5.25M-4.21M-2.87M
Share-based CompensationStock Comp.
0.03M0.02M0.02M1.50M6.76M0.18M5.26M5.26M0.34M6.44M0.14M0.11M0.05M0.34M1.18M0.03M4.38M0.00M24.21M24.21M
Deferred Taxes
-0.12M0.05M-0.06M-0.92M
Gains from Investment SecuritiesGains Investment
0.01M229.00-1.93M
Asset Writedowns and ImpairmentWritedown
3.50M11.11M2.29M10.30M-17.11M8.13M0.49M
Cash from OperationsCash from Ops.
-0.73M-0.67M-0.89M-3.17M-1.81M-2.80M-4.41M-1.82M-3.04M-4.31M-5.23M-3.20M-1.15M-0.92M-2.00M-1.41M-3.19M-3.10M-2.12M-1.92M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.27M0.19M0.18M0.11M0.08M0.01M0.00M0.10M0.00M
Amortization of Deferred ChargesAmort. Deferred Charges
0.18M0.11M
Depreciation & Amortization (CF)Dep. & Amort.
0.00M0.00M0.00M0.04M0.21M0.20M0.20M0.12M0.00M0.00M0.00M0.00M0.01M0.00M
Change in Working Capital
Change in ReceivablesChange Receivables
0.12M-0.09M-0.08M-0.07M-0.01M-0.01M-0.01M0.29M-0.27M-0.04M
Change in InventoryChange Inventory
0.25M0.02M0.04M0.12M-0.05M-0.05M0.09M-0.02M0.00M-462.00-0.01M0.08M
Change in Account PayablesChange Payables
0.15M0.20M0.35M0.14M-0.13M0.73M-1.24M1.66M0.99M1.95M-1.02M-1.17M0.95M-0.24M-0.26M-0.01M-0.78M-0.05M-0.22M0.31M
Change in Accured ExpensesChange Accured Exp.
0.06M0.31M0.90M0.33M1.54M-1.02M-0.21M-0.78M0.01M0.03M-0.26M-0.63M-0.18M-0.06M0.27M-0.28M-0.43M-0.14M-0.06M-0.03M
Investing Activities
Capital ExpendituresCapex
0.01M0.00M0.03M-0.02M6.10M0.00M0.02M0.00M0.00M
Cash from Investing ActivitiesCash from Investing
-0.01M-0.01M-0.01M-0.00M-0.04M-10.00M0.17M1.22M-0.00M-0.02M-0.00M-0.00M
Financing Activities
Other financing activitiesOther financing
-0.82M8.14M9.15M1.93M0.40M0.50M0.38M
Cash from Financing ActivitiesCash from Financing
-0.14M17.57M6.82M8.72M-0.58M-0.05M-0.21M1.30M5.21M-0.34M0.58M1.30M2.87M0.74M4.29M6.55M0.63M4.17M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.10M0.10M0.25M0.54M313.00751.0013.0026.00
Net Equity Issued and RepurchasedNet Equity Issued
9.15M5.03M1.37M-21.0021.00
Additional items
Exchange Rate EffectFX Effect
-0.06M0.03M-0.02M-0.08M0.06M-0.63M-0.56M0.93M-0.01M-0.02M
Change in Cash
-0.93M-0.81M16.68M3.63M6.89M-3.38M-4.50M-12.03M-1.57M-3.10M-0.09M-3.53M-0.59M0.31M0.93M-1.29M0.55M4.38M-1.50M2.23M
Free Cash FlowFCF
-0.73M-0.67M-0.89M-3.18M-1.81M-2.83M-4.39M-7.92M-3.04M-4.31M-5.24M-3.22M-1.15M-0.92M-2.00M-1.41M-3.19M-3.10M-2.12M-1.92M
Net Cash FlowNCF
-0.73M-0.81M16.68M3.63M6.89M-3.38M-4.50M-12.03M-1.57M-3.10M-0.03M-3.56M-0.57M0.38M0.87M-0.67M1.10M3.45M-1.49M2.25M